These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20540038)

  • 21. Economic evaluation of intravenous iodinated contrast media in Italy.
    Iannazzo S; Vandekerckhove S; De Francesco M; Nayak A; Ronco C; Morana G; Valentino M
    Int J Technol Assess Health Care; 2014 Jan; 30(1):69-77. PubMed ID: 24485022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low incidence of nephrotoxicity following intravenous administration of iodinated contrast media: a prospective study.
    Castaldo P; Frascà GM; Brigante F; Ferrante L; Magi S; Pavani M; Skrami E; Giuseppetti GM; Polonara G; Amoroso S
    Eur Radiol; 2019 Jul; 29(7):3927-3934. PubMed ID: 30989349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
    McCullough PA; Bertrand ME; Brinker JA; Stacul F
    J Am Coll Cardiol; 2006 Aug; 48(4):692-9. PubMed ID: 16904536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis.
    McCullough PA; Brown JR
    Cardiorenal Med; 2011; 1(4):220-234. PubMed ID: 22164156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
    Hardiek KJ; Katholi RE; Robbs RS; Katholi CE
    J Diabetes Complications; 2008; 22(3):171-7. PubMed ID: 18413220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial.
    Weiland FL; Marti-Bonmati L; Lim L; Becker HC
    Acta Radiol; 2014 Jul; 55(6):715-24. PubMed ID: 24060817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media.
    LaBounty TM; Shah M; Raman SV; Lin FY; Berman DS; Min JK
    Am J Cardiol; 2012 Jun; 109(11):1594-9. PubMed ID: 22440116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-procedural bioimpedance vectorial analysis of fluid status and prediction of contrast-induced acute kidney injury.
    Maioli M; Toso A; Leoncini M; Musilli N; Bellandi F; Rosner MH; McCullough PA; Ronco C
    J Am Coll Cardiol; 2014 Apr; 63(14):1387-94. PubMed ID: 24530668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
    Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
    Werner S; Bez C; Hinterleitner C; Horger M
    PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study.
    From AM; Bartholmai BJ; Williams AW; McDonald FS
    Acta Radiol; 2008 May; 49(4):409-14. PubMed ID: 18415784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine iso-osmolar contrast media use and acute kidney injury following percutaneous coronary intervention for ST elevation myocardial infarction.
    Premawardhana D; Sekar B; Ul-Haq MZ; Sheikh A; Gallagher S; Anderson R; Copt S; Ossei-Gerning N; Kinnaird T
    Minerva Cardioangiol; 2019 Oct; 67(5):380-391. PubMed ID: 31527583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
    Zhang BC; Wu Q; Wang C; Li DY; Wang ZR
    J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C; Visconti G; Ricciardelli B; Condorelli G;
    EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
    N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
    J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
    Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
    Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of gadolinium for arterial interventions.
    Sambol EB; Van der Meer JG; Graham A; Goldstein LJ; Karwowski JK; Dayal R; Derubertis B; Kent KC
    Ann Vasc Surg; 2011 Apr; 25(3):366-76. PubMed ID: 21288688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of Iodixanol on renal function after intra-arterial administration in patients with end-stage kidney disease.
    Gerk U; Franke RP; Krüger-Genge A; Jung F
    Clin Hemorheol Microcirc; 2018; 70(4):391-398. PubMed ID: 30320567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.